|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
|
|---|---|---|---|
| Cash Flows from Operating Activities: | |||
| Net (loss) income | |||
| Adjustments to reconcile net (loss) income to net cash used in operating activities: | |||
| Interest earned on cash and marketable securities held in Trust Account | |||
| Changes in operating assets and liabilities: | |||
| Prepaid expenses | |||
| Accounts payable and accrued expenses | |||
| Net cash used in operating activities | |||
| Cash Flows from Investing Activities: | |||
| Investment of cash in Trust Account | |||
| Net cash provided by investing activities | |||
| Cash Flows from Financing Activities: | |||
| Proceeds from sale of Units, net of underwriting discounts paid | |||
| Proceeds from sale of Private Placements Warrants | |||
| Proceeds from promissory note - related party | |||
| Repayment of promissory note - related party | |||
| Payment of other offering costs | |||
| Payments for redemptions of Class A ordinary shares | |||
| Net cash used in financing activities | |||
| Net Change in Cash | |||
| Cash - Beginning of period | |||
| Cash - End of period | |||
| Non-cash investing and financing activities: | |||
| Deferred underwriting fee payable | |||
| Waived deferred underwriting discount | |||
| Remeasurement of Class A ordinary shares to redemption amount |
Loading...
